Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment.

Lückerath, Katharina; Trajkovic-Arsic, Marija; Mona, Christine E

Lückerath, Katharina; Trajkovic-Arsic, Marija; Mona, Christine E.

Afiliación

Lückerath K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany. Electronic address: katharina.lueckerath@uk-essen.de.
Trajkovic-Arsic M; Division of Solid Tumor Translational Oncology, DKTK and German Cancer Research Center (DKFZ) Partner Side Essen, Hufelandstrasse 15, 45147, Germany; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.
Mona CE; Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, 650 Charles E Young Drive S, Los Angeles, CA 90095, USA.

PET Clin ; 18(3): 409-418, 2023 Jul.

Article en En | MEDLINE | ID: mdl-36990945

Asunto(s)

Neoplasias; Serina Endopeptidasas; Humanos; Serina Endopeptidasas/genética; Serina Endopeptidasas/metabolismo; Medicina de Precisión; Proteínas de la Membrana/genética; Proteínas de la Membrana/metabolismo; Neoplasias/diagnóstico por imagen; Neoplasias/terapia; Fibroblastos/metabolismo; Línea Celular Tumoral; Microambiente Tumoral

Palabras clave

Combination therapy; Fibroblast activation protein; Radioligand; Theranostics; Tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Serina Endopeptidasas / Neoplasias Límite: Humans Idioma: En Revista: PET Clin Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google